Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R DAWSON

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Neuropharmacology|April 29, 1999
Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor proteinG R Seabrook, D W Smith, B J Bowery, et al.
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition|March 13, 2014
Alterations in working memory networks in amnestic mild cognitive impairmentE M Migo, M Mitterschiffthaler, O O'Daly, et al.
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition|August 4, 2015
Investigating virtual reality navigation in amnestic mild cognitive impairment using fMRIE M Migo, O O'Daly, M Mitterschiffthaler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2001
Loss of the major GABA(A) receptor subtype in the brain is not lethal in miceC Sur, K A Wafford, D S Reynolds, et al.
Cell|May 19, 1995
beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activityH Zheng, M Jiang, M E Trumbauer, et al.
Translational Psychiatry|December 12, 2013
The effects of ketamine and risperidone on eye movement control in healthy volunteersA Schmechtig, J Lees, A Perkins, et al.
Journal of Psychopharmacology (Oxford, England)|February 12, 2010
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humansJ R Atack, K A Wafford, L J Street, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 7, 2022
Theory of Mind and social functioning among neuropsychiatric disorders: A transdiagnostic studyS Braak, T Su, W Krudop, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 6, 2005
An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognitionG R Dawson, K A Maubach, N Collinson, et al.
Nature Neuroscience|May 18, 2000
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtypeR M McKernan, T W Rosahl, D S Reynolds, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Neuropharmacology|April 29, 1999
Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor proteinG R Seabrook, D W Smith, B J Bowery, et al.
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition|March 13, 2014
Alterations in working memory networks in amnestic mild cognitive impairmentE M Migo, M Mitterschiffthaler, O O'Daly, et al.
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition|August 4, 2015
Investigating virtual reality navigation in amnestic mild cognitive impairment using fMRIE M Migo, O O'Daly, M Mitterschiffthaler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2001
Loss of the major GABA(A) receptor subtype in the brain is not lethal in miceC Sur, K A Wafford, D S Reynolds, et al.
Cell|May 19, 1995
beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activityH Zheng, M Jiang, M E Trumbauer, et al.
Translational Psychiatry|December 12, 2013
The effects of ketamine and risperidone on eye movement control in healthy volunteersA Schmechtig, J Lees, A Perkins, et al.
Journal of Psychopharmacology (Oxford, England)|February 12, 2010
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humansJ R Atack, K A Wafford, L J Street, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 7, 2022
Theory of Mind and social functioning among neuropsychiatric disorders: A transdiagnostic studyS Braak, T Su, W Krudop, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 6, 2005
An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognitionG R Dawson, K A Maubach, N Collinson, et al.
Nature Neuroscience|May 18, 2000
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtypeR M McKernan, T W Rosahl, D S Reynolds, et al.
Pageof 6